Ethyl 4-(1-hydroxy-1-methylethyl)-2-propylimidazole-5-carboxylate

Catalog No. :
ACLTFO752
CAS No. :
144689-93-0
Molecular Formula :
C12H20N2O3
Molecular Weight :
240.30

IUPAC Name:ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate

Ethyl 4-(1-hydroxy-1-methylethyl)-2-propylimidazole-5-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g97%$60.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 4-(1-hydroxy-1-methylethyl)-2-propylimidazole-5-carboxylate
IUPAC Nameethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate
MDL No.MFCD07787565
Molecular FormulaC12H20N2O3
Molecular Weight240.30
SMILESOC(C)(C)C1=C([NH]C(=N1)CCC)C(=O)OCC
InChI KeyKZBJJAFGNMRRHN-UHFFFAOYSA-N
Synonym144689-93-0 | Ethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-imidazole-5-carboxylate | Ethyl 4-(1-hydroxy-1-methylethyl)-2-propylimidazole-5-carboxylate | 4-(1-hydroxy-1-methylethyl)-2-propyl-1H-imidazole-5-carboxylic acid ethyl ester | ethyl 4-(2-hydroxypropan-2-yl)
CAS No.144689-93-0
PubChem CID10562026

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACLTFO752 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACROVL912 route compound structure diagram
    ACROVL912144690-04-0 In Stock
  2. Plus
  3. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  4. Then
  5. ACLTFO752 route product structure diagram
    ACLTFO752144689-93-0 In Stock
Inquiry

2. ACLTFO752 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHGKB635 route compound structure diagram
    ACHGKB635144689-94-1 In Stock
  2. Then
  3. ACLTFO752 route product structure diagram
    ACLTFO752144689-93-0 In Stock
Inquiry

Comments (0)